Literature DB >> 7061657

Analysis of acetaminophen metabolites in urine by high-performance liquid chromatography with UV and amperometric detection.

J M Wilson, J T Slattery, A J Forte, S D Nelson.   

Abstract

Acetaminophen and several of its metabolites are separated isocratically on a reversed-phase (C18) column using a mobile phase of 7% methanol and 0.75% glacial acetic acid in 0.1 M KH2PO4. Metabolites that can be separated include the sulfate, glucuronide, cysteine, and mercapturic acid conjugates of acetaminophen, as well as 3-hydroxyacetaminophen, 3-methoxyacetaminophen, and 3-methylthioacetaminophen. Although all of the metabolites can be detected by UV spectrophotometry, the sensitivity limits of detection are improved significantly for acetaminophen and all of the metabolites except the sulfate and glucuronide, by amperometric detection (electrochemical) of the same sample as it elutes from the UV detector. Minimal detectable limits (signal-to-noise ratio greater than or equal to 2) for acetaminophen and its metabolites, other than the glucuronide and sulfate conjugates, were in the order of 1--2 ng injected on column using UV detection at 248 nm, and 0.1--0.5 ng using electrochemical detection at + 0.60 V with reference to an Ag/AgCl standard electrode.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7061657     DOI: 10.1016/s0378-4347(00)80398-9

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  Bioavailability study of paracetamol tablets in saliva and urine.

Authors:  P Retaco; M González; M T Pizzorno; M G Volonté
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Oct-Dec       Impact factor: 2.441

2.  A novel isocratic HPLC method to separate and quantify acetanilide and its hydroxy aromatic derivatives: 2-, 3- and 4-hydroxyacetanilide (paracetamol or acetaminophen).

Authors:  J Mancilla; E Valdes; L Gil
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

3.  Inhibition of the metabolism of paracetamol by isoniazid.

Authors:  M M Epstein; S D Nelson; J T Slattery; T F Kalhorn; R A Wall; J M Wright
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

4.  Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors.

Authors:  D Kwan; W R Bartle; S E Walker
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

5.  Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes.

Authors:  Marlon J A Jetten; Ainhoa Ruiz-Aracama; Maarten L J Coonen; Sandra M Claessen; Marcel H M van Herwijnen; Arjen Lommen; Joost H M van Delft; Ad A C M Peijnenburg; Jos C S Kleinjans
Journal:  Arch Toxicol       Date:  2015-06-24       Impact factor: 5.153

6.  Ratios of Acetaminophen Metabolites Identify New Loci of Pharmacogenetic Relevance in a Genome-Wide Association Study.

Authors:  Gaurav Thareja; Anne M Evans; Spencer D Wood; Nisha Stephan; Shaza Zaghlool; Anna Halama; Gabi Kastenmüller; Aziz Belkadi; Omar M E Albagha; Karsten Suhre
Journal:  Metabolites       Date:  2022-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.